World - Results from #14349

Tue Oct 5

How Theranos' faulty blood tests got to market – and what that shows about gaps in FDA regulation

Written by: Ana Santos Rutschman, Assistant Professor of Law, Saint Louis University

Theranos promised that a drop of blood could yield many health secrets. RapidEye/E+ via Getty Images

One of the most high-profile trials of the year is underway to decide whether Theranos founder Elizabeth Holmes defrauded patients and investors.

Her blood testing startup, once valued at almost US$10 billion, was based on a seemingly revolutionary...

The Times recently argued that Australia should keep building the data centres the AI economy requ...

Nikon is developing a new series of nine NIKKOR Z CINEMA T1.9 VV cinema lenses, designed for cinem...

The conflict around Iran and the Strait of Hormuz has entered a more dangerous phase, with the Uni...

The Times recently argued that Australia should keep building the data centres the AI economy requ...

The Australian-born fitness brand is bringing its global competition home, with athletes from across...

Two Years Later looks, initially, like a romantic television series. It is considerably more inte...

Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...

Two Years Later looks, initially, like a romantic television series. It is considerably more inte...

K-Pop Demon Hunters kids disco and free face painting headline a day of activities for local familie...

Batmobile, Bluey & Bingo, a reptile show and a petting zoo across the September/October break ...